Jiangsu (SH:688426) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2026-02-24 22:35Core Viewpoint - Jiangsu Kangwei Century Biotechnology Co., Ltd. has announced a change in its continuous supervision sponsor representative from Yang Ling to Wang Wei, ensuring the orderly continuation of the supervision work by CITIC Securities [1][2]. Group 1 - CITIC Securities is the sponsor institution for the company's initial public offering (IPO) and listing project on the Shanghai Stock Exchange's Sci-Tech Innovation Board [1]. - The continuous supervision period is set to last until December 31, 2025 [1]. - Wang Wei has been appointed to replace Yang Ling as the sponsor representative, while Jiang Hao remains in the role, ensuring no disruption in the supervision process [1]. Group 2 - The board of directors expressed gratitude for Yang Ling's contributions during the continuous supervision period of the IPO project [2]. - Wang Wei holds a master's degree and is currently a senior vice president at CITIC Securities Investment Banking Management Committee [3]. - Wang Wei has been involved in several major projects, including the IPOs of Ruili Kemi and Kangwei Century, among others [3].